Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Xerox Holdings Corp. (XRX)
NASDAQIndustrialsBusiness Equipment & SuppliesSnapshot 2026-11-05
$1.11-5.93%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsBusiness Equipment & SuppliesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.43 → 0.06 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for XRX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Generate approximately $250 million free cash flow in 2026 | The company plans about $250 million in free cash flow. | Intact | Free cash flow falls below $250 million in FY26 | Free cash flow: $7M FY2026-Q3; GAAP. Published target: >= $250 million. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 20267,000,000 USD · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a turnaround-style thesis, not a steady compounder: profitability has improved, while total revenue remains under pressure. The thesis is still in a watch state, with medium evidence confidence and elevated risk.
The valuation model indicates XRX is expensive versus peers, with a meaningful expectations gap driven by possible re-rating. Confidence in that valuation signal is low, and the evidence says expensive valuation is the main source of fragility rather than a broader stack of weaknesses.
Near term, recent results show better adjusted operating income and margin, helped by integration synergies and cost discipline, but Q3 revenue declined year over year and 2026 adjusted operating income guidance was reduced. Over the multi-year view, revenue stabilization and debt reduction remain incomplete: long-term debt was higher than at year-end 2025, despite specific debt exchanges and other reduction steps. Recent earnings beats and a strategic partnership are positive events, but the supplied evidence gives few details about the partnership.
The thesis depends on whether margin gains can continue while total revenue stabilizes and leverage comes down. A guidance cut on the next call would be a negative signal; continued earnings strength and higher guidance from sector bellwether ACCO would support the sector backdrop, while misses or lower guidance there could remove that support.
For the next 1 to 3 years, XRX has real operating progress but an unfinished turnaround, with revenue weakness, debt, and volatile execution still central to the long-term thesis. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Xerox Holdings Corp.'s published investment case. The stated target is Maintain stable leadership and deliver on strategic initiatives. |
| Under Pressure |
| Further management instability or failure to execute key plans |
Op Income $450M-$475M vs $555M-$605M target Xerox forecast Q3 adjusted operating income below target range and suspended dividends, signaling financial distress. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve $450-$500 million adjusted operating income in 2026 | It targets $450-$500 million in operating income. | Under Pressure | Operating income falls below $450 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue above $7.5 billion in 2026 | Xerox aims for revenue above $7.5 billion in 2026. | Intact | Revenue falls below $7.5 billion in FY26 | Revenue: $1.868B FY2026-Q3; GAAP. Published target: >= $7.5 billion. Annual target cannot be compared with a quarterly or TTM observation. Nov 5, 20261,868,000,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.93 → $0.06 · observed estimates
$7.48B → $7.45B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.93 | $7,484,172,840 | 1 / 2 |
| 2026-07-25 | $0.93 | $7,484,172,840 | 1 / 2 |
| 2026-07-26 | $0.93 | $7,484,172,840 | 1 / 2 |
| 2026-07-27 | $0.93 | $7,484,172,840 | 1 / 2 |
| 2026-07-28 | $0.93 | $7,484,172,840 | 1 / 2 |
| 2026-07-29 | $0.86 | $7,484,172,839 | 1 / 2 |
| 2026-07-30 | $0.86 | $7,484,172,839 | 1 / 2 |
| 2026-07-31 | $0.93 | $7,484,172,840 | 1 / 2 |
| 2026-08-01 | $0.81 | $7,477,085,590 | 1 / 2 |
| 2026-08-02 | $0.23 | $7,474,131,100 | 1 / 2 |
| 2026-08-03 | $0.23 | $7,474,131,100 | 1 / 2 |
| 2026-08-04 | $0.23 | $7,474,131,100 | 1 / 2 |
| 2026-08-05 | $0.47 | $7,474,354,000 | 1 / 2 |
| 2026-08-06 | $0.23 | $7,474,131,100 | 1 / 2 |
| 2026-08-08 | $0.47 | $7,474,354,000 | 1 / 2 |
| 2026-08-09 | $0.30 | $7,466,754,070 | 2 / 3 |
| 2026-08-10 | $0.47 | $7,474,354,000 | 1 / 2 |
| 2026-08-12 | $0.30 | $7,466,754,070 | 2 / 3 |
| 2026-08-13 | $0.30 | $7,466,754,070 | 2 / 3 |
| 2026-08-14 | $0.47 | $7,474,354,000 | 1 / 2 |
| 2026-08-15 | $0.47 | $7,474,354,000 | 1 / 2 |
| 2026-08-16 | $0.47 | $7,474,354,000 | 2 / 2 |
| 2026-08-17 | $0.47 | $7,474,354,000 | 2 / 2 |
| 2026-08-18 | $0.47 | $7,474,354,000 | 2 / 2 |
| 2026-08-19 | $0.47 | $7,474,354,000 | 2 / 2 |
| 2026-08-20 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-08-21 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-22 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-23 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-24 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-25 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-26 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-27 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-28 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-29 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-30 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-08-31 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-01 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-02 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-03 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-04 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-05 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-06 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-07 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-08 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-09 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-10 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-11 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-12 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-13 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-14 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-15 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-16 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-17 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-18 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-19 | $0.43 | $7,464,177,000 | 2 / 3 |
| 2026-09-20 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-21 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-22 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-23 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-24 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-25 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-26 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-27 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-28 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-29 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-09-30 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-01 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-02 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-03 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-04 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-05 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-06 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-07 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-08 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-09 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-10 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-11 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-12 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-13 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-14 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-15 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-16 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-17 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-18 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-19 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-20 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-21 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-22 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-23 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-24 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-25 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-26 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-27 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-28 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-29 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-30 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-10-31 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-11-01 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-11-02 | $0.43 | $7,464,177,000 | 1 / 3 |
| 2026-11-03 | $0.06 | $7,446,107,825 | 1 / 3 |
| 2026-11-04 | $0.06 | $7,446,107,825 | 1 / 3 |
| 2026-11-05 | $0.06 | $7,446,107,825 | 1 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 1 Hold · 2 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 2 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.